medical cannabis
medical cannabis · page 42
- Medical
Kanabo makes £14m acquisition of telehealth GP service
Patients will now be able to access Kanabo’s medical cannabis and CBD products through The GP Service (GPS).
- Medical
Khiron totals 16 medical cannabis clinics across the globe
The European medical cannabis group’s presence reaches Colombia, Peru and the UK.
- Medical
Little Green Pharma wins Italian tender for medical cannabis shipment
The Australian-based company is one of just two to bid for the tender.
- Cultivation
Proposal for medical cannabis facility put forward on Isle of Man
A public consultation has now been launched on the science innovation and research centre that will be established by Peel NRE.
- Medical
Exploring barriers in the UK’s medical cannabis industry
Director of AquaLabs, Callie Seaman, discusses what needs to be done to develop the UK medical cannabis industry.
- Adult-Use
UK cannabis industry calls for government to implement new policies
New policy suggestions include moving the licensing authority from the Home Office to the Department of Health and Social Care and making updates to the Proceeds of Crime Act.
- Hemp Industry
Strategic partnership sees Canxchange enter medical cannabis market
Medical cannabis products can now be bought and sold via Canxchange’s electronic trading infrastructure.
- Companies
Apollon Formularies intends to advance to a larger exchange
The cross-trading announcement follows requests from several US investors.
- Cultivation
First seeds planted at Ananda’s medical cannabis research facility
The AQSE Growth Market listed company has now begun the first stage of its research programme.
- Medical
Apollon Formularies opens new cannabis cancer and pain clinic in Jamaica
The grand opening of the clinic will expand Apollon’s patient treatment programme and generate additional revenue.
- Companies
UK police drug tests don’t work and criminalise cannabis patients
Scientists, patients and reform organisations are calling for the UK to rethink its policy on roadside cannabis testing as a new study has highlighted the shortcomings of the UK’s roadside drug tests.
- Pharmaceutical
Oxford Cannabinoid Technologies sees changes across the board
Richard Guy Hathaway has been appointed as non-executive director, and Julie Pomeroy has been appointed non-executive chair.
